Clinical Trials Update:&nbsp;Aug. 25, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
588883
roundup Plus: Rice lab makes nano parts less toxic...TV chip company gets $19 million...Oracle extends deadline on PeopleSoft bid...MLB sells game clips for 99 cents.
371936
roundup Plus: Siebel moves toward self-repairing software...Monster says it could enter Japan by mid-2005...Novell to release Open Enterprise Server.
197909
roundup Plus: IBM gives grants to universities...Sun expands pay-as-you go supercomputing...SGI works on Linux performance software.
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
705157
roundup Plus: HP rakes in .Net dough...Escend raises $3 million...Hitachi cuts 10 percent of U.S. work force...Evite goes local with invitations.
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
73400
Research and Markets (http://www.researchandmarkets.com/reports/c49927)  announces the addition of Frost & Sullivan's  new report Advances in Biomaterials for Medical Device Applications to  their offering.
415778
NEW YORK, December 24  - The Food &amp; Drug Administration (FDA) announced yesterday that it planned to examine the various studies that link the usage of several painkillers with heightened cardiovascular risks, while recommending that
153875
BOSTON, Oct. 29 /PRNewswire/ -- Data to be presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) demonstrated that treatment with the Bristol-Myers Squibb
380219
New board will focus on safety of drugs already on the market. Also: Flarion makes bold moves to spur expansion of infrastructure for its mobile data technology.... Texas Instruments can make cheaper 3G phones.... and more.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
703885
roundup Plus: WebSideStory cuts IPO to 4.4 million shares...BMC looks to simplify network operations...Data center firms settle cookie suit.
447650
Treatment with melatonin significantly improved subjective sleep quality in 12 women with mild to moderate asthma, as compared with 10 asthmatic women who took placebo, according to a study in the first issue for November 2004 of the American Thoracic
400180
Description: A new study finds that deaths in cancer drug trials have declined ten-fold, thanks to the development of drugs that are better targeted at the tumors themselves.
519863
The company faces a pivotal clinical trial.
727464
roundup Plus: Supercomputer center gets new No. 2...MIT, Caltech offer low-tech voting advice...Siemens builds phone to detect bad breath.